Acura takes $200K loan from Abuse Deterrent Pharma; warns of bankruptcy risk without more funding by Sept 2026

ACURA PHARMACEUTICALS, INC

Received $200,000 loan from AD Pharma on 8/14/2026; total principal now $11,094,279 with ~$1,290,000 accrued interest.
Loan bears 5.25% interest, rising to 7.5% on overdue amounts; proceeds used for day-to-day operations.
Without additional financing by late-September 2026, may furlough staff, scale back operations, or seek bankruptcy protection.
Company warns of possible complete loss of shareholder value if operations must cease.
Note and accrued interest currently due/negotiable by December 31, 2026.

Featured in Daily 8-K Digest

Selected #4 for 2026-08-20. Read digest

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.